Genedx Holdings Corp (WGS)

$88.11 +6.11 (7.45%)
Market Cap 2.58B
Revenue (ttm) 427.54M
Net Income (ttm) -21.02M
EPS (ttm) N/A
PE Ratio 58.16
Forward PE 109.33
Profit Margin -4.92%
Debt to Equity Ratio 0.16
Volume 1,201,800
Avg Vol 736,350
Day's Range N/A - N/A
Shares Out 29.29M
Stochastic %K 93%
Beta 2.03
Analysts Strong Sell
Price Target $156.67

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 888 729 1206
Fax: 201 421 2010
Address:
North Tower, 6th Floor 333 Ludlow Street, Stamford, United States
Exponential_increase
Exponential_increase Mar. 8 at 1:37 AM
$WGS Is that a bullish continuation wedge?
0 · Reply
Doozio
Doozio Mar. 7 at 7:13 PM
$WGS weekly bullish engulfer at da bahhhhhtom. 🐒🍌🧠⏰♾️
0 · Reply
Jasooon
Jasooon Mar. 7 at 2:24 AM
$WGS Holy smokes
1 · Reply
Agost1990
Agost1990 Mar. 6 at 7:39 PM
$WGS April fool 🤷🏻‍♂️
0 · Reply
Joseph_Ballin
Joseph_Ballin Mar. 6 at 12:34 AM
$WGS $13.4M insider purchase https://www.sec.gov/Archives/edgar/data/1307631/000119312526094527/xslF345X05/ownership.xml
0 · Reply
TimisoaraTitans
TimisoaraTitans Mar. 5 at 8:27 PM
$WGS $WGS c suite ?! Hello ! Where’s your army of trolls rushing to the defence…
0 · Reply
TimisoaraTitans
TimisoaraTitans Mar. 5 at 8:24 PM
$WGS these views are my own. Please tell me what I am missing.
0 · Reply
TimisoaraTitans
TimisoaraTitans Mar. 5 at 8:22 PM
$WGS zero engagement = zero volume. Race to the bottom.
0 · Reply
TimisoaraTitans
TimisoaraTitans Mar. 5 at 8:17 PM
$WGS steaming turd. Search for Genedx on google maps and read customer reviews. Overpricedc complacent stinking sh1t. Look after your customers
0 · Reply
Stackdoe101
Stackdoe101 Mar. 3 at 7:38 PM
$WGS 🫠✨
0 · Reply
Latest News on WGS
HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Feb 25, 2026, 8:03 PM EST - 11 days ago

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

GeneDx to Participate in Upcoming Investor Conferences

Feb 25, 2026, 8:30 AM EST - 11 days ago

GeneDx to Participate in Upcoming Investor Conferences

These Analysts Slash Their Forecasts On GeneDx After Q4 Results

Feb 24, 2026, 12:40 PM EST - 12 days ago

These Analysts Slash Their Forecasts On GeneDx After Q4 Results

GeneDx: The Growth Story Isn't Dead, It's Changing (Rating Upgrade)

Feb 24, 2026, 7:50 AM EST - 12 days ago

GeneDx: The Growth Story Isn't Dead, It's Changing (Rating Upgrade)

GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript

Feb 23, 2026, 12:34 PM EST - 13 days ago

GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript

INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

Feb 23, 2026, 8:07 AM EST - 13 days ago

INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

Feb 23, 2026, 6:30 AM EST - 13 days ago

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health

Feb 11, 2026, 9:05 AM EST - 25 days ago

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health

Polen 5Perspectives Small Growth Portfolio Performance & Attribution

Feb 5, 2026, 1:50 AM EST - 4 weeks ago

Polen 5Perspectives Small Growth Portfolio Performance & Attribution

BN

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

Feb 3, 2026, 8:00 AM EST - 4 weeks ago

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

Jan 15, 2026, 11:24 AM EST - 7 weeks ago

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

GeneDx Holdings Corp. (WGS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 8:15 PM EST - 7 weeks ago

GeneDx Holdings Corp. (WGS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum

Jan 14, 2026, 10:21 AM EST - 7 weeks ago

GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum

Why is GeneDx stock crashing on Monday?

Jan 12, 2026, 3:03 PM EST - 7 weeks ago

Why is GeneDx stock crashing on Monday?

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

Jan 12, 2026, 7:30 AM EST - 7 weeks ago

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

Jan 8, 2026, 8:30 AM EST - 2 months ago

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

Jan 7, 2026, 8:30 AM EST - 2 months ago

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

Jan 6, 2026, 8:30 AM EST - 2 months ago

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

Jan 5, 2026, 8:30 AM EST - 2 months ago

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

Dec 30, 2025, 8:00 AM EST - 2 months ago

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

Dec 15, 2025, 8:30 AM EST - 2 months ago

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

Eight stock picks to play one of the healthiest corners of the market

Dec 11, 2025, 10:37 AM EST - 3 months ago

Eight stock picks to play one of the healthiest corners of the market

ALNY ASND INSM MASI NTRA PODD UNH

6 Healthcare Stocks With Strong Upward Momentum

Nov 18, 2025, 12:59 PM EST - 3 months ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN GH MEDP

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

Nov 6, 2025, 8:00 AM EST - 4 months ago

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 3:41 PM EDT - 4 months ago

GeneDx Holdings Corp. (WGS) Q3 2025 Earnings Call Transcript

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

Oct 28, 2025, 6:30 AM EDT - 4 months ago

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth

Oct 27, 2025, 8:00 AM EDT - 4 months ago

GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

Oct 27, 2025, 8:00 AM EDT - 4 months ago

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

Oct 22, 2025, 8:00 AM EDT - 4 months ago

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

Oct 20, 2025, 8:00 AM EDT - 4 months ago

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

Oct 15, 2025, 3:30 PM EDT - 5 months ago

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Oct 15, 2025, 11:45 AM EDT - 5 months ago

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Oct 15, 2025, 9:15 AM EDT - 5 months ago

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

ILMN

GeneDx's Blueprint For The Next Healthcare Revolution

Oct 15, 2025, 2:55 AM EDT - 5 months ago

GeneDx's Blueprint For The Next Healthcare Revolution

How GeneDX CEO Katherine Stueland is using AI to save lives

Oct 14, 2025, 3:17 PM EDT - 5 months ago

How GeneDX CEO Katherine Stueland is using AI to save lives

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

Oct 14, 2025, 8:00 AM EDT - 5 months ago

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

Oct 13, 2025, 8:00 AM EDT - 5 months ago

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

Oct 9, 2025, 8:00 AM EDT - 5 months ago

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

Oct 8, 2025, 8:00 AM EDT - 5 months ago

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

Oct 7, 2025, 8:00 AM EDT - 5 months ago

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

Oct 1, 2025, 4:01 PM EDT - 5 months ago

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

Sep 30, 2025, 8:00 AM EDT - 5 months ago

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

Sep 25, 2025, 8:00 AM EDT - 5 months ago

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

Sep 18, 2025, 8:00 AM EDT - 6 months ago

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 10:45 AM EDT - 6 months ago

GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Seer Appoints Isaac Ro to its Board of Directors

Sep 2, 2025, 7:00 AM EDT - 6 months ago

Seer Appoints Isaac Ro to its Board of Directors

SEER

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

Aug 6, 2025, 9:30 AM EDT - 7 months ago

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

Exponential_increase
Exponential_increase Mar. 8 at 1:37 AM
$WGS Is that a bullish continuation wedge?
0 · Reply
Doozio
Doozio Mar. 7 at 7:13 PM
$WGS weekly bullish engulfer at da bahhhhhtom. 🐒🍌🧠⏰♾️
0 · Reply
Jasooon
Jasooon Mar. 7 at 2:24 AM
$WGS Holy smokes
1 · Reply
Agost1990
Agost1990 Mar. 6 at 7:39 PM
$WGS April fool 🤷🏻‍♂️
0 · Reply
Joseph_Ballin
Joseph_Ballin Mar. 6 at 12:34 AM
$WGS $13.4M insider purchase https://www.sec.gov/Archives/edgar/data/1307631/000119312526094527/xslF345X05/ownership.xml
0 · Reply
TimisoaraTitans
TimisoaraTitans Mar. 5 at 8:27 PM
$WGS $WGS c suite ?! Hello ! Where’s your army of trolls rushing to the defence…
0 · Reply
TimisoaraTitans
TimisoaraTitans Mar. 5 at 8:24 PM
$WGS these views are my own. Please tell me what I am missing.
0 · Reply
TimisoaraTitans
TimisoaraTitans Mar. 5 at 8:22 PM
$WGS zero engagement = zero volume. Race to the bottom.
0 · Reply
TimisoaraTitans
TimisoaraTitans Mar. 5 at 8:17 PM
$WGS steaming turd. Search for Genedx on google maps and read customer reviews. Overpricedc complacent stinking sh1t. Look after your customers
0 · Reply
Stackdoe101
Stackdoe101 Mar. 3 at 7:38 PM
$WGS 🫠✨
0 · Reply
healthcareguru
healthcareguru Mar. 2 at 8:34 PM
$WGS dramatically oversold vs fundamentals…starting to load up.
0 · Reply
tymtested
tymtested Mar. 2 at 5:30 PM
$WGS Looks like "UP" has gone. Where is the bottom???
0 · Reply
tymtested
tymtested Mar. 2 at 4:55 PM
$WGS HHHMMMMM...?
0 · Reply
Streetdilly1
Streetdilly1 Feb. 27 at 9:44 PM
$FLGT $460 mkt cap. $811 million cash. $WGS or $TEM should takeover this mismanaged company
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 27 at 2:27 PM
$WGS RSI: 46.85, MACD: -7.5243 Vol: 5.98, MA20: 89.23, MA50: 109.63 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
11thestate
11thestate Feb. 26 at 2:42 PM
Imagine buying $WGS (formerly CM Life Sciences) at its peak, only to watch it slide — and then discovering there may be a way to recover part of your losses. To all $WGS investors out there, we’ve got some important news for you: https://11th.com/cases/cmls-investor-settlement
0 · Reply
DARKP00L
DARKP00L Feb. 24 at 5:42 PM
$WGS 12:40 on Feb. 24 2026 These Analysts Slash Their Forecasts On GeneDx After Q4 Results #tradeideas
1 · Reply
erevnon
erevnon Feb. 24 at 11:30 AM
BTIG maintains GeneDx Holdings $WGS at Buy and lowers the price target from $200 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Feb. 23 at 8:56 PM
$WGS Massive volume spike with 1.68M shares traded, almost double the average volume. Recent price action shows a wide range from $82.06 to $92.04. Current price at $87.12 is closer to the lower end of recent prices. Waiting for a lower H% before considering entry.
0 · Reply
CarverX
CarverX Feb. 23 at 6:16 PM
$WGS Short party is over as you can see from the desperate multiple scaremonger posts. Don’t let them and their games steal your shares. 🚀🚀🚀
0 · Reply
d_risk
d_risk Feb. 23 at 4:34 PM
$WGS - GeneDx Holdings Corp - 10K - Updated Risk Factors WGS adds new risks around expanding use of AI (including Fabric Genomics) amid evolving global AI laws, tighter FDA uncertainty for LDTs and limits of Breakthrough Device status, geographic concentration vulnerabilities, potential tax-asset and goodwill impairments, integration of Fabric Genomics, loss of emerging growth company protections, a new IT controls material weakness, and possibly worthless 2026 warrants. #Genomics #ArtificialIntelligence #RegulatoryRisk #FDAUncertainty #FinancialImpairments 🟢 Added 🟠 Removed https://d-risk.ai/WGS/10-K/2026-02-23
0 · Reply
amberajax2point0
amberajax2point0 Feb. 23 at 3:56 PM
$WGS some beaten up healthcare growth names $PODD, seeing some love today
0 · Reply